METROPOLITAN LIFE INSURANCE CO/NY - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$175,971
-16.0%
3,504
+5.7%
0.01%
-10.0%
Q2 2023$209,508
+40.5%
3,3150.0%0.01%
+25.0%
Q1 2023$149,142
-7.4%
3,315
-9.8%
0.01%
+14.3%
Q4 2022$161,089
-33.5%
3,6770.0%0.01%
-41.7%
Q3 2022$242,278
+30.4%
3,6770.0%0.01%
+50.0%
Q2 2022$185,725
-20.9%
3,6770.0%0.01%0.0%
Q1 2022$234,887
-85.3%
3,677
-75.3%
0.01%
-63.6%
Q4 2021$1,595,082
+1.2%
14,892
-2.8%
0.02%
-4.3%
Q3 2021$1,575,666
+11.6%
15,326
-4.5%
0.02%
+15.0%
Q2 2021$1,411,934
-3.5%
16,052
+6.7%
0.02%
-9.1%
Q1 2021$1,463,214
-16.3%
15,049
-3.5%
0.02%
-15.4%
Q4 2020$1,748,643
+19.9%
15,592
-0.9%
0.03%
+4.0%
Q3 2020$1,457,986
+13.4%
15,728
-4.6%
0.02%
+8.7%
Q2 2020$1,286,142
+35.3%
16,489
+1.5%
0.02%
+15.0%
Q1 2020$950,475
-23.4%
16,253
+4.9%
0.02%
-4.8%
Q4 2019$1,241,304
+5.9%
15,495
-2.9%
0.02%
+5.0%
Q3 2019$1,172,067
-16.5%
15,953
+7.2%
0.02%
-16.7%
Q2 2019$1,403,158
+31.8%
14,875
+11.9%
0.02%
+26.3%
Q1 2019$1,064,425
+46.5%
13,297
-1.3%
0.02%
+26.7%
Q4 2018$726,491
-30.9%
13,4760.0%0.02%
-21.1%
Q3 2018$1,051,937
-99.9%
13,4760.0%0.02%
+35.7%
Q2 2018$855,456,000
-30.8%
13,4760.0%0.01%
-17.6%
Q1 2018$1,235,750,000
+129162.6%
13,476
+6.3%
0.02%
+30.8%
Q4 2017$956,000
-47.8%
12,672
-51.8%
0.01%
+18.2%
Q3 2017$1,831,000
+36.1%
26,279
-1.0%
0.01%
+22.2%
Q2 2017$1,345,000
+96.1%
26,542
+54.7%
0.01%
+80.0%
Q1 2017$686,000
+57.0%
17,155
+10.2%
0.01%
+66.7%
Q4 2016$437,000
-5.4%
15,5660.0%0.00%0.0%
Q3 2016$462,000
+46.7%
15,5660.0%0.00%
+50.0%
Q2 2016$315,000
+110.0%
15,566
+87.9%
0.00%
+100.0%
Q1 2016$150,000
-35.9%
8,285
-6.7%
0.00%
-50.0%
Q4 2015$234,000
+23.2%
8,8830.0%0.00%
+100.0%
Q3 2015$190,000
-19.8%
8,883
-0.8%
0.00%
-50.0%
Q2 2015$237,0008,9540.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders